EXACT Sciences Corporation Stock News

Cognios Capital LLC lowered its stake in shares of EXACT Sciences Co. (NASDAQ:EXAS) by 7.6% during the first quarter, according to the company in its most recent disclosure with the Securities & Excha

Artemis Investment Management LLP reduced its position in EXACT Sciences Co. (NASDAQ:EXAS) by 21.5% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 115,748 shares

On Aytu BioScience's (AYTU) upcoming earnings call, investor focus will be on its distribution right to commercialize the COVID-19 IgG/IgM Rapid Test in North America.

During Novavax's (NVAX) upcoming Q1 earnings call, investor focus will be on the company's progress with its seasonal influenza vaccine candidate, NanoFlu, and the COVID-19 vaccine candidate.

EXACT Sciences Co. (NASDAQ:EXAS) – Research analysts at SVB Leerink lifted their Q1 2020 earnings estimates for EXACT Sciences in a report issued on Wednesday, April 22nd. SVB Leerink analyst P. Sou

Assenagon Asset Management S.A. purchased a new stake in shares of EXACT Sciences Co. (NASDAQ:EXAS) during the 1st quarter, according to the company in its most recent filing with the SEC. The fund pu

EXACT Sciences Co. (NASDAQ:EXAS) – Investment analysts at Oppenheimer lowered their Q1 2020 EPS estimates for shares of EXACT Sciences in a research note issued on Tuesday, April 21st. Oppenheimer a

Abeona's (ABEO) operating expenses are expected to have increased in the first quarter driven by clinical studies on its lead gene therapy candidate.

IDEXX's (IDXX) business is likely to have benefited from few cases in which pets were found to be COVID-19 positive globally.

Boston Scientific's (BSX) business trends in the first two months of the quarter in line with its expectations.

Illumina (ILMN) is upbeat about its first-quarter sequencing consumable revenue growth.

Illumina (ILMN) is upbeat about its first-quarter sequencing consumable revenue growth.

ResMed (RMD) is expected to have gained from increased adoption of flagship products and a ramped-up ventilator production capacity in Q3 amid the coronavirus pandemic.

ResMed (RMD) is expected to have gained from increased adoption of flagship products and a ramped-up ventilator production capacity in Q3 amid the coronavirus pandemic.

DNB Asset Management AS reduced its stake in EXACT Sciences Co. (NASDAQ:EXAS) by 15.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange C